Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$1.52−0.09 (-5.30%)
Close on Nov 17, 2026Market cap $24.93MP/E –Yield –
Cellyan Biotechnology total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cellyan Biotechnology's total debt was $877.90K at Mar 31, 2026. For fiscal 2026 it was $877.90K, down 60.9% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $877.90K | -60.9% |
| FY2025 | Mar 31, 2025 | $2.25M | +68.4% |
| FY2024 | Mar 31, 2024 | $1.33M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $877.90K | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $2.05M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $2.25M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $1.33M | – |
See a number that looks wrong?